S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update
- PMID: 32413222
- DOI: 10.1111/ddg.14097_g
S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update
References
Literatur
-
- Eming R, Sticherling M, Hofmann SC et al. S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges 2015; 13: 833-44.
-
- Schmidt E, Goebeler M, Hertl M et al. S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges 2015; 13: 713-27.
-
- Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) - Ständige Komission Leitlinien. AWMF-Regelwerk „Leitlinien“. Available from http://www.awmf.org/leitlinien/awmf-regelwerk.html [Last accessed November 11, 2019].
-
- Boulard C, Duvert Lehembre S, Picard-Dahan C et al. Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus. Br J Dermatol 2016; 175: 142-9.
-
- Garcia-Melendez ME, Eichelmann K, Salas-Alanis JC et al. Pemphigus foliaceus in an 11-year-old mexican girl with response to oral dapsone. Case Rep Pediatr 2013; 2013: 291256.
LinkOut - more resources
Full Text Sources